For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Codiak Biosciences, Inc.

USPTO Granted Patents = 12

EPO Patents = 3

Trademarks = 2

Forward Citations = 63

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Douglas E Williams (5 out of 17 patents)

Jan Lötvall (5 out of 6 patents)

John D Kulman (4 out of 21 patents)

4. Ke Xu (3 out of 9 patents)

5. Hadi Valadi (3 out of 4 patents)

6. Kevin P Dooley (3 out of 6 patents)

7. Sriram Sathyanarayanan (2 out of 9 patents)

8. Rane A Harrison (2 out of 5 patents)

9. Russell E McConnell (2 out of 4 patents)

10. Damian J Houde (2 out of 6 patents)

11. Nikki Ross (2 out of 6 patents)

12. Sonya Haupt (2 out of 4 patents)

13. Jonas Andrej Nilsson (2 out of 2 patents)

14. Nuruddeen D Lewis (1 out of 3 patents)

15. Yu Zhou (1 out of 3 patents)

12 patents: Sort by Forward Citations

1. 12648907 - MEMBRANE PROTEIN SCAFFOLDS FOR EXOSOME ENGINEERING (2026-06-09),

2. 12622876 - METHODS OF SUPPRESSING DELIVERY OF EXOSOMES TO LIVER AND SPLEEN (2026-05-12),

3. 12616712 - STING AGONIST COMPRISING EXOSOMES FOR TREATING NEUROIMMUNOLOGICAL DISORDERS (2026-05-05),

4. 11679164 - Preparation of therapeutic exosomes using membrane proteins (2023-06-20),

5. 11512315 - Methods and compositions for macrophage polarization (2022-11-29),

6. 10723782 - Exosomes for immuno-oncology and anti-inflammatory therapy (2020-07-28),

7. 10695443 - Exosome transfer of nucleic acids to cells (2020-06-30),

8. 10370663 - Delivery of therapeutic agent (2019-08-06),

9. 10195290 - Preparation of therapeutic exosomes using membrane proteins (2019-02-05),

10. 9889210 - Exosome transfer of nucleic acids to cells (2018-02-13),

11. 9856477 - Delivery of therapeutic agent (2018-01-02),

12. 9629929 - Exosome transfer of nucleic acids to cells (2017-04-25),

Codiak Biosciences, Inc. is a leading biotechnology company focused on harnessing exosomes – natural vesicles secreted by all cells – to create a new class of medicines. The company's proprietary technology platform enables the design and engineering of exosome therapeutics for the treatment of a broad range of diseases, with an initial focus on oncology and neurology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Codiak Biosciences, Inc.

12 Patents

#202 in Cambridge, MA

#1,543 in Massachusetts

#25,494 in US

#48,027 in the World

Cambridge, MA, United States of America

Codiak Biosciences, Inc.

Forward Citations = 63

23 inventors:

Douglas E Williams (5 out of 17 patents)

Jan Lötvall (5 out of 6 patents)

John D Kulman (4 out of 21 patents)

4. Ke Xu (3 out of 9 patents)

5. Hadi Valadi (3 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…